COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04VHZ
|
|||
Drug Name |
Interferon-alpha 2b
|
|||
Synonyms |
alb-IFN
|
|||
Drug Type |
Protein/peptide drug
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) | Phase 1 | [1] | |
Other Indication | Hairy cell leukaemia | Approved | [2] | |
Therapeutic Class |
Antiviral Agents
|
References | Top | |||
---|---|---|---|---|
1 | ClinicalTrials.gov (NCT04293887) Efficacy and Safety of IFN-2 in the Treatment of Novel Coronavirus Patients. U.S. National Institutes of Health. | |||
2 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 103132. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.